Managing risk with established and new therapies in the cardiorenal metabolic patient (InConversation held on 5 June 2025)

CPD-Q&A-Banner-(deNovo)-InConversation-Spotlight-On-Episode-3

Learning objectives:

  • Review the pathophysiology and classification of CKM syndrome
  • Identify key risk factors and clinical implications
  • Review current treatment strategies
  • Emphasise the importance of early detection and multidisciplinary management.

To access this module, please register or login: